[EN] PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5- MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS [FR] PRÉPARATION ET PROCÉDÉS D'UTILISATION D'ORTHO-ARYLE HÉTÉROARYLE À 5 CHAÎNONS -CARBOXAMIDE CONTENANT DES INHIBITEURS DE KINASES MULTICIBLES
Copper catalyzed access to functionalized oxazoles from oximes via carbenoids
作者:Anugula Nagaraju、K. Sandeep、K.C. Kumara Swamy
DOI:10.1016/j.tetlet.2018.05.004
日期:2018.6
straightforward synthesis of diverse oxazoles from oximes possessing a vicinal carbonyl group has been achieved by treatment of the latter with terminal diazo compounds like ethyl/benzyl diazoacetate and diazoacetophenone (which act as carbenoids) in one pot. At least two reducible functional groups (two ester groups or cyano + ester) are simultaneously introduced in one step. This reaction involves expulsion
PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS
申请人:Flynn Gary A.
公开号:US20140228367A1
公开(公告)日:2014-08-14
The present disclosure relates to compounds of the Formula (I):
and pharmaceutically acceptable salts, as kinase modulators, compatible with the Type-II inhibition of kinases.
本公开涉及式(I)的化合物及其药学上可接受的盐,作为酶调节剂,与激酶的II型抑制相兼容。
Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
申请人:Flynn Gary A.
公开号:US09221805B2
公开(公告)日:2015-12-29
The present disclosure relates to compounds of the Formula (I):
and pharmaceutically acceptable salts, as kinase modulators, compatible with the Type-II inhibition of kinases.
本公开涉及公式(I)的化合物以及药学上可接受的盐,作为激酶调节剂,与激酶的二型抑制相兼容。
[EN] PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5- MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS<br/>[FR] PRÉPARATION ET PROCÉDÉS D'UTILISATION D'ORTHO-ARYLE HÉTÉROARYLE À 5 CHAÎNONS -CARBOXAMIDE CONTENANT DES INHIBITEURS DE KINASES MULTICIBLES
申请人:FLYNN GARY A
公开号:WO2013022766A1
公开(公告)日:2013-02-14
The present disclosure relates to compounds of the Formula (I): and pharmaceutically acceptable salts, as kinase modulators, compatible with the Type-II inhibition of kinases.
本公开涉及式(I)的化合物及其药用可接受盐,作为激酶调节剂,与激酶的II型抑制相兼容。
Stereoselective Lewis Base-Catalyzed Asymmetric Hydrosilylation of α-Acetamido-β-enamino Esters: Straightforward Approach for the Construction of α,β-Diamino Acid Derivatives
The Lewis base‐organocatalyzed asymmetric hydrosilylation of α‐acetamido‐β‐enamino esters was investigated. Among various chiral Lewis base catalysts, a novel catalyst derived from L‐serine was found to be the most efficient one which can promote the reaction to afford a series of α,β‐diaminoacidderivatives with high yields (up to 99%), excellent enantioselectivities (up to 98% ee) and moderate